IMMUNITRACK ApS: Financial statements 2024
CVR: 32347908
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. That is an increase of 2,600.5% compared with the year before. Equity in the 2024 report amounted to DKK 21,211,816. The solvency ratio was 85.6%.
- Gross Profit
- DKK 141,975,865
- Profit/Loss
- DKK 110,009,470
- Equity
- DKK 21,211,816
- Total Assets
- DKK 24,768,522
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 142 mio. | 110 mio. | 21.2 mio. | 0 |
| 2023 | - | 5.3 mio. | -194 t. | 12.8 mio. | 12 |
| 2022 | - | 5.5 mio. | 1.2 mio. | 10.2 mio. | 11 |
| 2021 | - | 4.5 mio. | 257 t. | 7.7 mio. | 9 |
| 2020 | - | 1.1 mio. | -1.2 mio. | 4.9 mio. | 8 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
IMMUNITRACK ApS has published its interim report for the period June 1, 2023 – December 31, 2023.
As of May 1, 2024, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of IMMUNITRACK ApS.
As of May 1, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of IMMUNITRACK ApS.
As of May 1, 2024, Christopher Henry Anderson has joined the board of directors of IMMUNITRACK ApS.
As of May 1, 2024, Philip Leo Johnson has left the board of directors of IMMUNITRACK ApS.
As of May 1, 2024, Michael C Thompson is registered as adm. dir. of IMMUNITRACK ApS.
As of May 1, 2024, Philip Leo Johnson has stepped down as adm. dir. of IMMUNITRACK ApS.
About IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company has been dissolved. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees (2018). In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity in the 2024 report amounted to DKK 21,211,816.